Patents by Inventor Gavin Iain Welsh

Gavin Iain Welsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VECTOR
    Publication number: 20230175016
    Abstract: The present invention provides a viral vector comprising a nucleotide sequence encoding a complement protein, wherein the nucleotide sequence is operably linked to a podocyte-specific promoter and/or the viral vector is capable of specifically transducing podocytes.
    Type: Application
    Filed: June 30, 2021
    Publication date: June 8, 2023
    Inventors: Alan William Griffith, Lukas Stanczuk, Valeryia Kuzmuk, Chris Hollowood, Dominic Schmidt, Moin Ahson Saleem-Uddin, Gavin Iain Welsh
  • GENE THERAPY
    Publication number: 20230101788
    Abstract: The present invention provides an adeno-associated virus (AAV) vector gene therapy comprising a vascular endothelial growth factor (VEGF)C transgene; and minimal nephrin promoter NPHS1 or podocin promoter NPHS2. The gene therapy vector can be used to target podocytes within the glomerulus of the kidney in order to treat or prevent kidney disease, such as diabetic kidney disease.
    Type: Application
    Filed: March 4, 2021
    Publication date: March 30, 2023
    Applicant: THE UNIVERSITY OF BRISTOL
    Inventors: Rebecca R. Foster, Moin Ahson Saleem-Uddin, Gavin Iain Welsh
  • THERAPY
    Publication number: 20210402008
    Abstract: The application provides gene therapies for treating monogenic forms of nephrotic syndrome.
    Type: Application
    Filed: June 15, 2021
    Publication date: December 30, 2021
    Inventors: Moin Ahson Saleem-Uddin, Gavin Iain Welsh, Wen Yi Ding